Structure of fredericamycin A, an antitumor antibiotic of a novel skeletal type. Spectroscopic and mass spectral characterization.
- 1 January 1987
- journal article
- research article
- Published by Japan Antibiotics Research Association in The Journal of Antibiotics
- Vol. 40 (6) , 786-802
- https://doi.org/10.7164/antibiotics.40.786
Abstract
IR, UV-visible spectroscopy, circular dichroism, 1H and 13C NMR studies, high resolution electron impact, field desorption, and fast atom bombardment mass spectral studies are reported for fredericamycin A (NSC-305263), a novel antitumor antiobiotic of acid-base indicator type produced by Streptomyces griseus (FCRC-48). The spectral data are correlated with the structure obtained by X-ray crystallography as (E,E)-6'',7''-dihydro-4,9,9''-trihydroxy-6-methoxy-3''-(1,3-pentadienyl)-spiro-[2H-benz[f]indene-2,8''-[8H]-cyclopent-[g]-isoquinoline]-1,1'',3,5,8(2''H)-pentone. The novel spiro ring antibiotic exhibits unusual 1H and 13C NMR spectroscopic and chemical behavior, not previously observed in other antibiotic structures.This publication has 4 references indexed in Scilit:
- Magnetic resonance studies of fredericamycin A: evidence for oxygen-dependent free-radical formationBiochemistry, 1986
- Biosynthesis of fredericamycin A, a new antitumor antibioticBiochemistry, 1985
- Fredericamycin A a new antitumor antibiotic. II. Biological properties.The Journal of Antibiotics, 1981
- Fredericamycin A a new antitumor antibiotic. I. Production, isolation and physicochemical properties.The Journal of Antibiotics, 1981